Mammography Screening and Breast Cancer Mortality

Authors

  • Catharina Endah Wulandari Independent Practicing Physician, Alumna of Faculty of Medicine Diponegoro University, Semarang, Indonesia

DOI:

https://doi.org/10.55175/cdk.v51i12.1139

Keywords:

Breast cancer, mammography, screening

Abstract

Breast cancer is the most common cancer in Indonesia and one of the biggest contributor to cancer mortality. About 70% breast cancers are detected at an advanced stage which makes the mortality rate even higher. Several measures have been taken to detect breast cancer early, including mammography screening. Mammography is X-ray imaging used to detect abnormalities in breast cancer. The American College of Radiology recommends breast cancer screening for at-risk women starting at age 40. However, whether mammography screening can reduce breast cancer mortality is still debatable. 

Downloads

Download data is not yet available.

References

Sari A. Skrining mamografi dan mortalitas kanker payudara. J MKMI. 2019;15(1):1-6. DOI: 10.30597/mkmi.v15i1.5501.

The Global Cancer Observatory (GLOBOCAN). Cancer data - Indonesia. International Agency for Research on Cancer [Internet]. 2020. Availablefrom: https://gco.iarc.who.int/media/globocan/factsheets/populations/360-indonesia-fact-sheet.pdf.

Reeves R, Kaufman T. Mammography [Internet]. 2023 [cited 2023 Nov 15]. Available from: https://www.ncbi.nlm.nih.gov/books/NBK559310/.

Monticciolo DL, Newell MS, Hendrick RE, Helvie MA, Moy L, Monsees B, et al. Breast cancer screening for average-risk women: Recommendations from the ACR commission on breast imaging. J Am Coll Radiol. 2017;14(9):1137-43. DOI: 10.1016/j.jacr.2017.06.001.

Gerami R, Joni S, Akhondi N, Etemadi A, Fosouli M, Eghbal AF, et al. A literature review on the imaging methods for breast cancer. Int J Physiol Pathophysiol Pharmacol. 2022;14(3): 171–6. PMID: 35891932.

Ginsburg O, Yip C, Brooks A, Cabanes A, Caleffi M, Yataco JA, et al. Breast cancer early detection: A phased approach to implementation. Cancer 2020;126(10):2379–93. DOI: 10.1002/cncr.32887.

Gunawan A. Pemilihan pemeriksaan imaging untuk skrining karsinoma mammae. Cermin Dunia Kedokteran 2021;48(6):347–9. DOI: 10.55175/cdk.v48i6.86.

Soekersi H, Azhar Y, Akbari K. Peran mammografi untuk skrining kanker payudara: Sebuah tinjauan pustaka. J Indon Med Assoc. 2002;72(3):144-50.

American Cancer Society. Breast cancer early detection and diagnosis [Internet]. 2022 [cited 2024 May 13]. Available from: https://www.cancer.org/content/dam/CRC/PDF/Public/8579.00.pdf.

Berg WA, Zhang Z, Lehrer D, Jong RA, Pisano ED, Barr RG, et al. Detection of breast cancer with addition of annual screening ultrasound or a singlescreening MRI to mammography in women with elevated breast cancer risk. JAMA. 2012;307(13):1394-404. DOI: 10.1001/jama.2012.388.

Siu AL, US Preventive Services Task Force. Screening for breast cancer: U.S. preventive services task force recommendation statement. Ann Intern Med. 2016;164(4):279-96. DOI: 10.7326/M15-2886.

Rojas K, Stuckey A. Breast cancer epidemiology and risk factors. Clin Obstet Gynecol. 2016;59(4):651-72. DOI: 10.1097/GRF.0000000000000239.

Kowalski AE. Mammograms and mortality: How has the evidence evolved? J Econ Perspect. 2021;35(2):119–40. DOI: 10.1257/jep.35.2.119.

Flemban AF. Overdiagnosis due to screening mammography for breast cancer among women aged 40 years and over: A systematic review and meta-analysis. J Pers Med. 2023;13(3):523. DOI: 10.3390/jpm13030523.

Liu J, Lei J, Ou Y, Zhao Y, Tuo X, Zhang B, et al. Mammography diagnosis of breast cancer screening through machine learning: A systematic review and meta-analysis. Clin Exp Med. 2023;23(6):2341-56. DOI: 10.1007/s10238-022-00895-0.

Dibden A, Offman J, Duffy S, Gabe R. Worldwide review and meta-analysis of cohort studies measuring the effect of mammography screening programmes on incidence-based breast cancer mortality. Cancers (Basel). 2020;12(4):976. DOI: 10.3390/cancers12040976.

Duffy S, Vulkan D, Cuckle H, Parmar D, Sheikh S, Smith R, et al. Effect of mammographic screening from age 40 years on breast cancer mortality (UK Age trial): Final results of a randomised, controlled trial. Lancet Oncol. 2020;21(9):1165-72. DOI: 10.1016/S1470-2045(20)30398-3.

Maroni R, Massat R, Parmar D, Dibden A, Cuzick J, Sasieni P, et al. A case-control study to evaluate the impact of the breast screening programme on mortality in England. Br J Cancer 2021;124(4):736–43. DOI: 10.1038/s41416-020-01163-2.

Narod S, Sun P, Wall C, Baines C, Miller A. Impact of screening mammography on mortality from breast cancer before age 60 in women 40 to 49 years of age. Curr Oncol. 2014;21(5):217-21. DOI: 10.3747/co.21.2067.

Duffy S, Tabar L, Yen A, Dean P, Smith R, Jonsson H, et al. Beneficial effect of consecutive screening mammography examinations on mortality from breast cancer: A prospective study. Radiology. 2021;299(3):541–47. DOI: 10.1148/radiol.2021203935.

Mayor S. Mammography screening has little or no effect on breast cancer deaths, Swedish data indicate. BMJ. 2012;345:e4847. DOI: 10.1136/bmj.e4847.

Christiansen R, Autier P, Stovring H. Change in effectiveness of mammography screening with decreasing breast cancer mortality: A population-based study. Eur J Public Health 2022;32(4):630–5. DOI: 10.1093/eurpub/ckac047.

Kementerian Kesehatan RI. Peraturan Menteri Kesehatan Republik Indonesia Nomor 34 Tahun 2015 Tentang Penanggulangan Kanker Payudara dan Kanker Leher Rahim. Kemenkes RI [Internet]. 2015. Available from: http://hukor.kemkes.go.id/uploads/produk_hukum/PMK_No._34_ttg_Penanggulangan_Kanker_Payudara_dan_Leher_Rahim_.pdf.

Kementerian Kesehatan RI. Pedoman teknis pengendalian kanker payudara dan kanker leher rahim. Direktorat Pengendalian Penyakit Tidak Menular [Internet]. 2016. Available from: https://p2ptm.kemkes.go.id/dokumen-ptm/pedoman-teknis-pengendalian-kanker-payudara-kanker-leher-rahim.

Published

05-12-2024

How to Cite

Wulandari, C. E. (2024). Mammography Screening and Breast Cancer Mortality. Cermin Dunia Kedokteran, 51(12), 722–725. https://doi.org/10.55175/cdk.v51i12.1139